全文获取类型
收费全文 | 7596篇 |
免费 | 595篇 |
国内免费 | 403篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 279篇 |
妇产科学 | 152篇 |
基础医学 | 871篇 |
口腔科学 | 154篇 |
临床医学 | 890篇 |
内科学 | 1521篇 |
皮肤病学 | 108篇 |
神经病学 | 287篇 |
特种医学 | 527篇 |
外国民族医学 | 2篇 |
外科学 | 675篇 |
综合类 | 967篇 |
预防医学 | 439篇 |
眼科学 | 140篇 |
药学 | 589篇 |
3篇 | |
中国医学 | 295篇 |
肿瘤学 | 625篇 |
出版年
2024年 | 19篇 |
2023年 | 60篇 |
2022年 | 188篇 |
2021年 | 232篇 |
2020年 | 191篇 |
2019年 | 209篇 |
2018年 | 204篇 |
2017年 | 177篇 |
2016年 | 189篇 |
2015年 | 313篇 |
2014年 | 380篇 |
2013年 | 330篇 |
2012年 | 469篇 |
2011年 | 462篇 |
2010年 | 388篇 |
2009年 | 322篇 |
2008年 | 329篇 |
2007年 | 408篇 |
2006年 | 364篇 |
2005年 | 365篇 |
2004年 | 205篇 |
2003年 | 204篇 |
2002年 | 207篇 |
2001年 | 189篇 |
2000年 | 161篇 |
1999年 | 174篇 |
1998年 | 200篇 |
1997年 | 239篇 |
1996年 | 177篇 |
1995年 | 149篇 |
1994年 | 167篇 |
1993年 | 124篇 |
1992年 | 65篇 |
1991年 | 70篇 |
1990年 | 64篇 |
1989年 | 80篇 |
1988年 | 86篇 |
1987年 | 69篇 |
1986年 | 66篇 |
1985年 | 61篇 |
1984年 | 35篇 |
1983年 | 19篇 |
1982年 | 29篇 |
1981年 | 33篇 |
1980年 | 27篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 19篇 |
1976年 | 27篇 |
1975年 | 16篇 |
排序方式: 共有8594条查询结果,搜索用时 15 毫秒
101.
102.
HPLC法测定冠心通络片中橙皮苷的含量 总被引:1,自引:0,他引:1
目的:建立冠心通络片中橙皮苷含量的测定方法。方法:采用高效液相色谱法,色谱柱为HypersilODSC18(5μm,4.6mm×100mm);流动相为甲醇-5%醋酸溶液(30∶70);检测波长为283nm;柱温为30℃;流速为1.0mL/min。结果:橙皮苷在419.2~2096μg(r=0.9998,n=5)范围内呈良好的线性关系;平均回收率98.71%;RSD为1.13%。结论:本法检测快速,定量准确,可用于冠心通络片的定量分析。 相似文献
103.
目的 :国内、美国风湿病学会 (ACR) 2种疗效判断标准评价洛索洛芬 (loxoprofen)治疗类风湿关节炎 (RA)的疗效及不良反应。方法 :选择 5 0例 ,年龄 (4 8±s 13)a ,4 0~ 69aRA活动期病人 (男女不限 ) ,口服洛索洛芬 60mg ,tid× 4wk ,比较用药前后关节压痛数、关节肿胀数、血沉、C反应蛋白等临床及实验室指标的变化 ,用国内、ACR不同疗效判断标准评价洛索洛芬治疗RA的疗效及不良反应。结果 :洛索洛芬治疗RA的总有效率达 74 %(国内标准 )和 80 % (ACR标准 ) ,2种疗效判断标准无显著差异 ,各项临床及实验室指标均有显著改善 ,不良反应发生率 10 % ,未出现危及生命的不良反应。结论 :洛索洛芬治疗RA安全、有效 相似文献
104.
105.
106.
Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen 总被引:1,自引:3,他引:1
Tamoxifen (TAM) is widely used as adjuvant breast cancer therapy after
surgery and as a chemopreventive agent in women of child-bearing age.
However, TAM therapy has been shown to result in an increased incidence of
endometrial carcinoma in women. The present study was designed to
investigate the effects of TAM (5 mg/kg and 7.5 mg/kg body wt) given i.g.
to pregnant CD-1 mice (1x/day, days 12 through 18 of gestation) on their
female offspring. Progressive proliferative hyperplasia of the oviduct was
frequently seen in TAM-exposed offspring, reaching 100% incidence by 52
weeks in both treatment groups. These females also developed progressive
proliferative uterine lesions, including moderate/severe cystic endometrial
hyperplasia (34-50%) and polypoid adenomas (27-30%) between 53 and 78
weeks. Deciduomas (15%) occurred at young ages (12 and 24 weeks) while
leiomyomas (14%), a malignant leiomyosarcoma, and ovarian granulosa cell
tumors (14%), were found between 72 and 78 weeks. Our findings thus suggest
a strong association between transplacental TAM and reproductive tract
abnormalities in female CD-1 mice.
相似文献
107.
P de Lonlay-Debeney JC Fournet D Martin F Poggi C Dionisi Vicci M Spada G Touati J Rahier F Brunelle C Junien JJ Robert C Nihoul-Fékété JM Saudubray 《Archives de pédiatrie》1998,5(12):1347-1352
Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most frequent cause of hypoglycaemia in infancy. Clinical presentation is heterogeneous, with variable onset of hypoglycaemia and response to diazoxide, and presence of sporadic or familial forms. Underlying histopathological lesions can be focal or diffuse. Focal lesions are characterised by focal hyperplasia of pancreatic islet-like cells, whereas diffuse lesions implicate the whole pancreas. The distinction between the two forms is important because surgical treatment and genetic counselling are radically different. Focal lesions correspond to somatic defects which are totally cured by limited pancreatic resection, whereas diffuse lesions require a subtotal pancreatectomy exposing to high risk of diabetes mellitus. Diffuse lesions are due to functional abnormalities involving several genes and different transmission forms. Recessively inherited PHHI have been attributed to homozygote mutations for the beta-cell sulfonylurea receptor (SUR1) or the inward-rectifying potassium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the glucokinase gene, particularly when PHHI is associated with diabetes, the glutamate dehydrogenase gene when hyperammonaemia is associated, or another locus. 相似文献
108.
OBJECTIVE: Because survival from admission to discharge does not provide parents and physicians information about future life expectancy in the premature neonate, we characterized the actuarial survival, defined as the future life expectancy from a given postnatal age, in a large inborn population of premature infants < 30 weeks' gestation. STUDY DESIGN: We determined daily actuarial survival of 1925 inborn infants (23 to 29 weeks' gestation) admitted to the Baylor Affiliated Nurseries from July 1986 through December 1994, stratified by 100-g birth weight and by 1-week gestational-age intervals. RESULTS: In the 501- to 600-g birth weight stratum, actuarial survival improved from 31% at birth, to 61% on day of life 7, and then to 75% on day of life 28; in the 901- to 1000-g birth weight stratum, actuarial survival improved from 88%, to 94%, and then to 98% throughout the same times, respectively. Similar trends were obtained when data were stratified by gestational age. CONCLUSIONS: Survival in the smallest infants improves dramatically during the first few days of life, but there is a significant risk for late death in the smallest of these infants. 相似文献
109.
OBJECTIVE: The ketogenic diet is a high-fat, low-protein, low-carbohydrate diet developed in the 1920s for the treatment of children with difficult to control seizures. Despite advances in both the pharmacotherapy and the surgery of epilepsy, many children continue to have difficult-to-control seizures. This prospective study sought to determine the ketogenic diet's effectiveness and tolerability in children refractory to today's medications. METHODS: One hundred fifty consecutive children, ages 1 to 16 years, virtually all of whom continued to have more than two seizures per week despite adequate therapy with at least two anticonvulsant medications, were prospectively enrolled in this study, treated with the ketogenic diet, and followed for a minimum of 1 year. Seizure frequency was tabulated from patients' daily seizure calendars and seizure reduction calculated as percentage of baseline frequency. Adverse events and reasons for diet discontinuation were recorded. RESULTS: The children (mean age, 5.3 years), averaged 410 seizures per month before the diet, despite an exposure to a mean of 6.2 antiepileptic medications. Three months after diet initiation, 83% of those starting remained on the diet and 34% had >90% decrease in seizures. At 6 months, 71% still remained on the diet and 32% had a >90% decrease in seizures. At 1 year, 55% remained on the diet and 27% had a >90% decrease in seizure frequency. Most of those discontinuing the diet did so because it was either insufficiently effective or too restrictive. Seven percent stopped because of intercurrent illness. CONCLUSIONS: The ketogenic diet should be considered as alternative therapy for children with difficult-to-control seizures. It is more effective than many of the new anticonvulsant medications and is well tolerated by children and families when it is effective. 相似文献
110.